Pereira H, SFL 2014. Stent for Life, Portugal



Similar documents
Stent for Life Initiative How can we improve system delay and patients delay in STEMI

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care

STEMI System of Care: Upland Hills Health A Transferring Non-PCI Facility. Estimated ground transport time: 54 minutes

HOTLINE 1 O doente está primeiro! A Plataforma de Dados na Saúde e o Registo Nacional de Cardiologia de Intervenção.

American Heart Association (AHA) Mission: Lifeline ND A Year in Review. 2013, American Heart Association 1

Private Sector Debt Dívida do Sector Privado. dossiers. Economic Outlook Conjuntura Económica. Conjuntura Económica.

Antiaggreganti. STEMI : cosa c è di nuovo? Heartline Genova Novembre 2015

Mission: Lifeline North Texas STEMI Workshop. The Model STEMI Referring Center (non-pci capable) Trisha Wren, RN, BSN

The EU Energy Tax Directive: overview about the proposed reform, impacts on national measures and state of play

Duration of Dual Antiplatelet Therapy After Coronary Stenting


Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Networking for optimal treatment of STEMI and NSTEMI. European Stent for life Project

The Transition to Tendering Perspective from the Manufacturing Industry

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

ACTION Registry GWTG Version 2.4

The Swedish approach: Quality Assurance with Clinical Quality Registries the RIKS-HIA example

HAAD JAWDA Quality KPI; waiting times. December 2015

California Health and Safety Code, Section

DO YOU LIVE IN A CARDIAC READY COMMUNITY?

Mission: Lifeline EMS Recognition Guide

Level crossing signs from the view of road users in Europe. Tamás Déri Hungarian NSA

Title (fr) SOURCE IONIQUE INTERNE DOUBLE POUR PRODUCTION DE FAISCEAU DE PARTICULES AVEC UN CYCLOTRON

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Emergency Management Strategies for Acute Myocardial Infarction - Code R at LGH

Czech Universities and the Environment for Innovation. Rudolf Hanka

egovernment Digital Agenda Scoreboard 2014

Your first EURES job. Progress Summary 2014Q4. March 2015

OHIM SEARCH TOOLS: TMVIEW, DSVIEW AND TMCLASS. Making trade mark and design information readily available for users

Online job search in the EU: The potential of web 2.0

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

EMR Tutorial Acute Coronary Syndrome

SME Instrument statistics

Member Profile. ANFH Finansieringsselskapenes Forening The Association of Norwegian Finance Houses

Milk Market Situation. Brussels, 27 August 2015

Reperfusion is so central to the modern

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

VERSION 1.1 SEPTEMBER 14, 2014 IGELU 2014: USE.PT UPDATE REPORT NATIONAL/REGIONAL USER GROUP REPRESENTATIVES MEETING PRESENTED BY: PAULO LOPES

ST Segment Elevation Nothing is ever as hard (or easy) as it looks

European Research Council

FH Studies Collaboration Lecturers at the European Society of Atherosclerosis Congress Pre- and Post- Event Questionnaires

Overview of VoD services in the EU & Future developments. Europa International Athens, 23 rd November 2013

European Research Council

έΰζβν αππ έκυ,νσϊίία κν1γν πλδζέκυνβί1γ π ηία δεόμνκαλ δκζόΰκμ, θν δ υγυθ άμνγνκαλ /εάμ ΚζδθδεάμΝ υλωεζδθδεάμν

ERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006

SURVEY ON THE TRAINING OF GENERAL CARE NURSES IN THE EUROPEAN UNION. The current minimum training requirements for general care nurses

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

EUROPEAN SEMESTER THEMATIC FICHE ACCESS TO FINANCE

INNOBAROMETER THE INNOVATION TRENDS AT EU ENTERPRISES

MM, EFES EN. Marc Mathieu

ECCE Standing Committee Education & Training

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

THE ROLE OF PUBLIC SUPPORT IN THE COMMERCIALISATION OF INNOVATIONS

Export of unemployment benefits

Fast Track to Innovation (FTI Pilot)

COHESION POLICY: STRATEGIC REPORT 2013

ERGP (12) 33 ERGP report on data collection ERGP REPORT WITH DATA ON INDICATORS ON THE POSTAL MARKET

The EU s 2030 Effort Sharing Agreement

Aktuelle Literatur aus der Notfallmedizin

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY

Ten Years of a Tele-ECG System in the State of Rio Grande do Sul/Brazil: From a Regional Project to a Multipoint Network

Payments to Overseas banks Things to be aware of

GLS Group Company presentation. June 2016, Neuenstein

Implementing a Prehospital 12-Lead Program

How can UK RUC plans benefit from the Eurovignette experience?

Dublin, March EPSO Network of Experts in the field of Personnel Selection 14th March 2013

Tackling undeclared work in the European Union and the EU candidate countries. Barbara Gerstenberger Eurofound

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

Katy Taylor, European Coalition to End Animal Experiments (ECEAE), London, UK

STEMI Systems of Care

SESAR. Luftfahrttechnologie - Auftaktveranstaltung zum 7. EU-Forschungsrahmenprogramm Wien, 4 Dezember 2006

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2012/21

The Legal Service of the European Commission. March

A Zero Waste Vision for Europe: management of resources and the key role of biowaste

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

Digital Agenda Targets Progress report. Digital Agenda Scoreboard 2014

Ohrid, 4 June 2012 NATIONAL BANK OF THE REPUBLIC OF MACEDONIA 5TH CONFERENCE ON PAYMENT AND SECURITIES SETTLEMENT SYSTEMS

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Reperfusion in STEMI. Pharmacoinvasive therapy The Krakow experience

The Bioresorbable Vascular Stent Dr Albert Ko

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Timely Administration of Thrombolytics for STEMI Within Nova Scotia Emergency Departments: How Do We Measure Up?

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo

Europass Curriculum Vitae

TEPZZ 9 Z5A_T EP A1 (19) (11) EP A1. (12) EUROPEAN PATENT APPLICATION published in accordance with Art.

Transcription:

Stent for Life, Portugal

Stent For SFL Initiative in Portugal: Improving quality by shortening patients and system delays in Portugal Hélder Pereira, SFL Champion Albufeira, 27 April2014

Stent for Life Portugal Where we started Quality Assessment Our Current Program Market Research Study Conclusion

Where we started 4

Implement an Action Plan to Increase P-PCI To increase the use of primary PCI to more than 70% among all ST segment elevation myocardial infarction patients, To achieve primary PCI rates of more than 600 per one million inhabitants per year, To offer 24/7 service for primary PCI procedures at all invasive facilities to cover the country STEMI population need. J.Knot: How to set up an effective national primary angioplasty network: lessons learned from five European countries (EuroIntervention, August 2009).

Stent for Life Reperfusion Therapies (<2008): Non Revascularized 37% 44% Fibrinolysis 19% Primary PCI <200 P-PCI/million/year Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. P. Widimsky et al. Eur. Heart.J. 2010;31:943-957 doi:10.1093/eurheartj/ehp492

Stent for Life Reperfusion Therapies Differ in Countries (situation in years 2007-2008 for most countries) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 7 1 14 12 17 13 10 15 15 20 0 25 21 26 26 7 30 2 12 36 40 39 35 37 5 15 44 42 3 31 52 48 50 50 8 10 63 40 15 15 35 55 92 28 35 86 26 30 81 81 44 75 75 72 70 25 33 66 64 59 41 45 49 45 45 29 35 33 30 30 28 24 23 19 19 9 8 5 CZ SLO DE CH NO DK PL HR SE HU BE IL IT FIN AT FR SK ES LAT UK BG PO SRB GR TR RO P-PCI Thrombolysis No reperfusion Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. P. Widimsky et al. Eur. Heart.J. 2010;31:943-957 doi:10.1093/eurheartj/ehp492

Stent for Life Reperfusion Therapies (2011): Non Revascularized 25% 7% Fibrinolysis 68% Primary PCI 299 P-PCI/million/year* Registo Nacional de SCA; SPC * PNDCCV Inquérito Unidades de Saúde 2011

Stent for Life Portugal Barriers Identification Patients E.M.S. network Hospital Only 23% of STEMI patients call 112 Communication with P-PCI Centers Strategic PCI Hospitals w/o 24/7 Long Patient Delay Secondary transport 9 Long System Delay

Where we are

Primary PCI Evolution 350 300 250 200 150 100 50 0 P-PCI/ Million/Year 2002-2013 299 306 228 243 264 179 105 118 125 132 152 334 * 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 From PNDCCV Inquérito Unidades de Saúde 2013 * From APIC Survey 2013

Steen D. Kristensen et al. Blue bars are data from 2007 and red bars are data from 2010/2011

Primary PCI vs Fibrinolysis Coronary Care Units 4000 3500 3179 3246 3000 2500 2415 2575 2829 2000 1500 1616 1900 Fibrinolysis P-PCI 1000 500 855 702 878 572 421 424 344 0 2006 2007 2008 2009 2010 2011 2012 From PNDCCV Inquérito Unidades de Saúde 2013

Primary PCI vs Other PCI 100% 18 21 21 23 24 25 26 80% 60% 40% P-PCI Other 20% 0% 2007 2008 2009 2010 2011 2012 2013

Primary PCI per Regions (2012) 500 P-PCI 2012 400 300 200 100 306 291 215 453 432 0 Continente Norte Centro LVT Alentejo Algarve 32 From PNDCCV Inquérito Unidades de Saúde 2013

500 Primary PCI per Regions (2012 vs 2013) 453 432438 400 300 200 334 306 291 291 287 215 367 256 100 0 Continente Norte Centro LVT Alentejo Algarve 32 From PNDCCV Inquérito Unidades de Saúde 2013

Quality Assessment

Quantity and Quality P-PCI/million/year Symptoms-FMC/ /Call 112 EMS System Delay

Quality Assessment Portuguese Registry of Interventional Cardiology Moment Survey Market Research Studies

Portuguese Registry of Interventional Cardiology (RNCI) Since 2013, all P-PCI centers are sending data to RNCI

Portuguese Registry of Interventional Cardiology

Portuguese Registry of Interventional Cardiology Benchmark:

Moment Survey (SFL Portugal) Moment Zero (n=201) May 2011 Moment One (n=196) May 2012 Moment Two (n=244) May 2013

Symptoms to FMC Symptoms-FMC Moment Two May 2013 Moment One May 2012 90 102 Moment Zero Moment One Moment Two Moment Zero May 2011 118 0 20 40 60 80 100 120 (min)

Patients who called INEM Call 112 40% 30% 33% 38% 37% 20% 10% 0% Moment Zero Momento One Momento Two May 2011 May 2012 May 2013

FMC - EKG Moment Two 15 Moment One 15 Moment Zero 17 (min) 0 10 20

(min) Time-to-Treatment - Primary PCI Center - D2B Moment Two 55 Moment One 53 Moment Zero 55 0 20 40 60

Time-to-Treatment Goals for P-PCI - Directly-Admitted vs Transferred Patients -

Time-to-Treatment Goals for P-PCI - Directly-Admitted Patients - Bates E et al. NEJM 2013:369;889

Time-to-Treatment Goals for P-PCI - Transfer Patients - Bates E et al. NEJM 2013:369;889

Three Different Scenarios: Patients transported by the EMS to P-PCI Hospitals Patients who transport themselves to P-PCI Hospitals Patients who transport themselves to Non-P-PCI Hospitals

Patients who underwent a health institution without P-PCI 70% 60% 50% 40% 30% 20% 10% 0% P=0,005 62% 47% 48% Moment Zero Moment One Moment Two May 2011 May 2012 May 2013 LOCAL HOSPITAL

Door-in-Door-out Time (DIDO) LOCAL HOSPITAL P-PCI HOSPITAL Moment Two 115 Moment One 106 Moment Zero 97 P=0,051 85 90 95 100 105 110 115

Door-to-Balloon Patients Arriving Directly to P-PCI Hospital: (2011-2013) 96 min (71-146) P<0,001 P-PCI HOSPITAL 50 min (30-75)

Manchester Triage Triage Moment Zero Moment One Moment Two p Red 5.4% (n=8) 10.6% (n=13) 5.7% (n=9) 0.184 Orange 77.7% (n=115) 66.7% (n=82) 78.3% (n=123) 0.042 Yellow 14.2% (n=21) 21.1% (n=26) 13.4% (n=21) 0.147 Other 2.7% (n=4) 1.6% (n=9) 2.5% (n=4) 0.852 17% 23% 16%

Time to Reperfusion Therapy Treatment Delay < 120 min: 12% 10% 8% 6% 8% 12% 9% 4% 2% 0% Moment Zero Moment One Moment Two May 2011 May 2012 May 2013

Stent for Life Portugal Quality Control: Moment Surveys Symptoms-FMC FMC-PPCI D2B Moment Two May 2013 90 100 55 Moment One May 2012 102 88 53 (min) Moment Zero May 2011 118 104 55 0 100 200 300 Patient Delay System Delay

Market Research Study

Market Research Study - Stent for Life - Sofia Portela slportela@iscte.pt Rui Menezes rui.menezes@iscte.pt February 2014

ACT NOW SAVE A LIFE What would you do in case of MI? Call a doctor Chamava um médico Telefonava a um familiar ou amigo Call a friend or relative Ia para o hospital de carro Go to a hospital by car 0% 1% 6% Other Call line Saúde 24 Press chest Basic life support Don t know Call an ambulance Chamava uma ambulância 91% Other Outro 2% Sofia Portela & Rui Menezes

ACT NOW SAVE A LIFE What s the emergency number? 95% 3% 1% 0% 1% 0% 0% Don t Não know sei 112 115 117 118 119 202 Sofia Portela & Rui Menezes

Patients who called INEM Call 112 40% 30% 33% 38% 37% 20% 10% 0% Moment Zero Momento One Momento Two

ACT NOW SAVE A LIFE Myocardial infarction and stroke are the same disease? 8% 16% 77% Sim Yes Não No Não Doesn t sei know 77 % answered No, however 25,5% do not know to describe any difference Sofia Portela & Rui Menezes

ACT NOW SAVE A LIFE What s the typical symptom of MI? Symptoms Sintomas related to enumerados MI têm todos a ver com enfarte 24% Any symptoms Nenhum is sintoma related to enumerado MI tem a ver com enfarte Alguns dos sintomas enumerados têm a ver com Some symptoms are related to MI, some other no enfarte e outros sintomas não 27% 28% All symptoms Todos are os related sintomas Stroke enumerados têm a ver com AVC Some symptoms Alguns are related dos sintomas MI, some enumerados other are têm related a ver to com stroke enfarte e outros têm a ver com AVC 4% 5% Do not know the typical Não symptom sei qual of o sintoma MI típico de enfarte 21% Sofia Portela & Rui Menezes

STEMI vs Stoke

Our Current Program

Stent for Life Programs STENT Follow goes to Primary Prevention Secondary Prevention the School STENT SAVE HER S LIFE Cost- -Effectiveness Study

North Regional Meetings (P-PCI Hospitals, Non-PCI Hospitals, EMS, Regional Authorities) Center LVT Alentejo Algarve North: Jorge Marques Centre: Marco Costa Lisbon and Vale do Tejo: Pedro Sousa Alentejo: Renato Fernandes Algarve: Jorge Mimoso

Improving quality by shortening patients and system delays in Portugal Summary: Patient delay: Maintain/increase the population awareness campaign; System delay: Consolidation of EMS-Hospital partnership; Improve the national network; Increase professional motivation; Other measures: Motivate industry partners; Persuade the Ministry of Health to be a partner of the campaign; Standardize optimal medical treatment; Educational programs for health personnel and patients

Conclusions Barriers Identification Patients E.M.S. network Hospital Only 23% of STEMI patients call 112 Communication with P-PCI Centers Strategic PCI Hospitals 24/7 Long Patient Delay Secondary transport Long System Delay

Thank you